| Literature DB >> 34086058 |
Michael Herzog1,2, Achim G Beule3,4, Jan-Christoffer Lüers5, Orlando Guntinas-Lichius6, Leigh J Sowerby7, Vasyl Bogdanov8, Daniel Grafmans8.
Abstract
PURPOSE: The SARS-CoV‑2 pandemic has affected the health and practice of otorhinolaryngologists (ORLs) for over 1 year. Follow-up data of a national survey with German ORLs were evaluated regarding differences between the two waves of the pandemic.Entities:
Keywords: COVID-19; ENT; ORL; Personal protective equipment; Risk
Mesh:
Year: 2021 PMID: 34086058 PMCID: PMC8176277 DOI: 10.1007/s00106-021-01075-4
Source DB: PubMed Journal: HNO ISSN: 0017-6192 Impact factor: 1.284
Fig. 1Course of SARS-CoV‑2 infection in Germany. a Cumulative number of individuals with SARS-CoV‑2 infection in Germany. b Cumulative number of ORLs with SARS-CoV‑2 infection in Germany. c Daily number of individuals with SARS-CoV‑2 infection in Germany. Data for Germany were derived from the Robert Koch Institute. Based on these data, a first (January 28, 2020 to July 31, 2020) and a second wave (August 1, 2020 to February 28, 2021) were defined
Age distribution of ORLs with SARS-CoV‑2 infection
| Age (years) | First wave | Second wave | ||
|---|---|---|---|---|
| Hospital ( | Private ( | Hospital ( | Private ( | |
| < 30 | 1 | 0 | 4 | 0 |
| 30–35 | 12 | 1 | 14 | 2 |
| 36–40 | 7 | 2 | 3 | 1 |
| 41–45 | 1 | 4 | 0 | 2 |
| 46–50 | 1 | 7 | 8 | 4 |
| 51–55 | 2 | 9 | 1 | 6 |
| 56–60 | 1 | 10 | 0 | 12 |
| 61–65 | 0 | 4 | 0 | 1 |
| 66–70 | 0 | 4 | 0 | 3 |
| > 70 | 0 | 0 | 0 | 2 |
Hospital ORLs working in a hospital environment, Private ORLs working in a private practice
Fig. 2Geographical distribution of ORLs with SARS-CoV‑2 infection. Infected ORLs are given in the table of each federal state of Germany. The red row represents the first wave, the green row the second wave. In each row the hospital ORLs are listed on the left side, the ORLs in private practice on the right side. During the first wave, ORLs were predominately affected in the west and south of Germany (NW, BW, BY). The second wave was more distinct in the eastern and southern part of Germany (SN, BB, BY). Abbreviation of federal states: BW Baden-Württemberg, BY Bavaria, BB Brandenburg, BE Berlin, HB Bremen, HH Hamburg, HE Hessen, MV Mecklenburg-West Pomerania, NI Lower Saxony, NW North Rhine-Westphalia, RP Rhineland-Palatinate, SL Saarland, SN Saxony, ST Saxony-Anhalt, SH Schleswig-Holstein, TH Thuringia
Geographical distribution and demographic correlation
| First wave | Second wave | Total | |||||
|---|---|---|---|---|---|---|---|
| Federal state | Inhabitants | Infected ORLs ( | % 10−4 | Infected ORLs ( | % 10−4 | Infected ORLs ( | % 10−4 |
| 11,100,394 | 10 | 0.9 | 4 | 0.36 | 14 | 1.26 | |
| 13,124,737 | 15 | 1.14 | 10 | 0.76 | 25 | 1.9 | |
| 2,521,893 | 2 | 0.79 | 5 | 1.98 | 7 | 2.78 | |
| 3,669,491 | 4 | 1.09 | 4 | 1.09 | 8 | 2.18 | |
| 681,202 | 1 | 1.47 | 2 | 2.94 | 3 | 4.4 | |
| 1,847,253 | 5 | 2.71 | 1 | 0.54 | 6 | 3.25 | |
| 6,288,080 | 1 | 0.16 | 4 | 0.64 | 5 | 0.8 | |
| 1,608,138 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 7,993,608 | 4 | 0.5 | 5 | 0.63 | 9 | 1.13 | |
| 17,947,221 | 12 | 0.67 | 9 | 0.5 | 21 | 1.17 | |
| 4,093,903 | 3 | 0.73 | 3 | 0.73 | 6 | 1.47 | |
| 986,887 | 0 | 0 | 1 | 1.01 | 1 | 1.01 | |
| 4,071,971 | 0 | 0 | 10 | 2.46 | 10 | 2.46 | |
| 2,194,782 | 4 | 1.82 | 4 | 1.82 | 8 | 3.65 | |
| 2,903,773 | 5 | 1.72 | 0 | 0 | 5 | 1.72 | |
| 2,133,378 | 0 | 0 | 1 | 0.47 | 1 | 0.47 | |
| 83,166,711 | 66 | 0.79 | 63 | 0.76 | 129 | 1.55 | |
The abbreviations of the federal states are given in the legend of Fig. 2
Symptoms, duration of infection, and therapy required for ORLs with COVID‑19
| First wave | Second wave | |||
|---|---|---|---|---|
| No symptoms | 6 | 9.1 | 5 | 7.6 |
| Fever | 34 | 51.5 | 27 | 40.9 |
| Cough | 26 | 39.4 | 23 | 34.8 |
| Coryza | 13 | 19.7 | 23 | 34.8 |
| Sore throat | 15 | 22.7 | 14 | 21.2 |
| Musculoskeletal pain | 29 | 43.9 | 34 | 51.5 |
| Fatigue | 44 | 66.7 | 41 | 62.1 |
| Dyspnea | 4 | 6.1 | 12 | 18.2 |
| Hyposmia | 26 | 39.4 | 21 | 31.8 |
| < 12 | 32 | 48.5 | 34 | 54.0 |
| 12–15 | 12 | 18.2 | 16 | 25.4 |
| 16–20 | 9 | 13.6 | 6 | 9.5 |
| 21–25 | 5 | 7.6 | 4 | 6.3 |
| 26–30 | 3 | 4.5 | 2 | 3.2 |
| > 30 | 5 | 7.6 | 1 | 1.6 |
| Domestic quarantine | 64 | 97.0 | 58 | 92.1 |
| Hospital regular care | 2 | 3.0 | 3 | 4.8 |
| Hospital intensive care unit | 0 | 0 | 2 | 3.2 |
Hospital ORLs working in a hospital environment, Private ORLs working in a private practice
Medical procedures performed by ORLs during the first and second wave
| Medical procedures | First wave | Second wave | ||
|---|---|---|---|---|
| Hospital ( | Private ( | Hospital ( | Private ( | |
| Examination | ||||
| Nose | 6 (24.0) | 10 (24.4) | 20 (66.6) | 23 (69.7) |
| Oral cavity | 7 (28.0) | 10 (24.4) | 22 (73.3) | 19 (57.6) |
| Pharynx/larynx | 7 (28.0) | 10 (24.4) | 21 (70.0) | 19 (57.6) |
| Ears | 6 (24.0) | 10 (24.4) | 17 (56.7) | 17 (51.5) |
| Endoscopy | 4 (16.0) | 10 (24.4) | 19 (63.3) | 16 (48.5) |
| Sonography | 0 (0) | 8 (19.5) | 8 (26.7) | 11 (33.3) |
| Nose and sinus surgery | 0 (0) | 2 (4.9) | 2 (6.7) | 5 (15.2) |
| Tonsillectomy | 0 (0) | 0 (0) | 2 (6.7) | 2 (6.1) |
| Tumor surgery | 1 (4.0) | 0 (0) | 1 (3.3) | 0 (0) |
| Ear surgery | 0 (0) | 0 (0) | 1 (3.3) | 0 (0) |
| Tracheostomy | 2 (8.0) | 0 (0) | 9 (30.0) | 0 (0) |
Medical procedures Procedures which were performed by the participants, Hospital ORLs working in a hospital environment, Private ORLs working in a private practice
Availability of personal protective equipment and perceived protection of hospital ORLs versus those in private practicea
| First wave | Second wave | |||||||
|---|---|---|---|---|---|---|---|---|
| Hospital ( | Private ( | Hospital ( | Private ( | |||||
| % | % | % | % | |||||
| Surgical mask | 25 | 100 | 37 | 90 | 30 | 100 | 32 | 97 |
| FFP2 | 18 | 72 | 18 | 44 | 29 | 97 | 28 | 85 |
| FFP3 | 8 | 32 | 5 | 12 | 7 | 23 | 5 | 15 |
| Protective glasses | 16 | 64 | 15 | 37 | 22 | 73 | 24 | 73 |
| Helmet/shield | 5 | 20 | 3 | 7 | 4 | 13 | 3 | 9 |
| PAPR | 1 | 4 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gloves | 25 | 100 | 38 | 93 | 27 | 90 | 30 | 91 |
| Protective coat | 22 | 88 | 13 | 32 | 25 | 83 | 23 | 70 |
| Mean | 2.52 | 3.49 | 2.17 | 2.61 | ||||
| SD | 1.17 | 1.25 | 0.78 | 1.15 | ||||
| 95% CI | 2.06; 2.98 | 3.10; 3.87 | 1.89; 2.45 | 2.21; 3.00 | ||||
FFP2/3 KN 95 mask or equivalent, PAPR powered air-purifying respirator, SD standard deviation, 95% CI 95% confidence interval, Hospital ORLs working in a hospital environment, Private ORLs working in a private practice
aPerceived protection measured via Likert scale “Did you feel protected against an infection with SARS-CoV‑2 during your professional activities?” Options of response: 1 = always; 2 = most of the time; 3 = sometimes; 4 = a little; 5 = never
Assumed and confirmed source of SARS-CoV‑2 infection for ORLs during first and second wave
| First wave | Second wave | |||||||
|---|---|---|---|---|---|---|---|---|
| Hospital ( | Private ( | Hospital ( | Private ( | |||||
| % | % | % | % | |||||
| Patient | 8 | 32 | 13 | 32 | 20 | 67 | 20 | 61 |
| Staff | 11 | 44 | 5 | 12 | 7 | 23 | 2 | 6 |
| Family | 5 | 20 | 2 | 5 | 4 | 13 | 6 | 18 |
| Neighborhood | 4 | 16 | 1 | 2 | 2 | 7 | 1 | 3 |
| General public | 0 | 0 | 0 | 0 | 1 | 3 | 1 | 3 |
| No contact | 4 | 16 | 21 | 51 | 2 | 7 | 11 | 33 |
| Yes | 1 | 4 | 10 | 24 | 8 | 27 | 10 | 30 |
| No | 11 | 44 | 4 | 10 | 11 | 37 | 7 | 21 |
| Unknown | 13 | 52 | 27 | 66 | 11 | 37 | 16 | 48 |
| Patient | 0 | 0 | 6 | 15 | 9 | 30 | 6 | 18 |
| Staff | 13 | 52 | 0 | 0 | 1 | 3 | 5 | 15 |
| Family | 2 | 8 | 2 | 5 | 5 | 17 | 4 | 12 |
| Neighborhood | 1 | 4 | 3 | 7 | 1 | 3 | 1 | 3 |
| General public | 0 | 0 | 0 | 0 | 3 | 10 | 1 | 3 |
| Unknown | 9 | 36 | 30 | 73 | 11 | 37 | 16 | 48 |